Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York, NY, June 12, 2024 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in real estate development, leasing and management, is pleased to announce the successful completion of a...
-
ROCHESTER, NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Syntec Optics (“Syntec”), a scientific and technical instruments and aerospace and defense mission-critical optics provider that further added...
-
ROCHESTER, NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Syntec Optics (“Syntec” or the “Company”) (Nasdaq: OPTX) named Dean Rudy Chief Financial Officer, effective June 10, 2024. Mr. Rudy succeeds...
-
New York, NY, June 07, 2024 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in real estate development, leasing and management, is pleased to announce the acquisition of a premier...
-
ROCHESTER, NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical optics to scientific and technical instruments and aerospace and defense...
-
ROCHESTER, NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical optics to scientific and technical instruments and aerospace and defense...
-
ROCHESTER, NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of mission-critical optics for scientific and technical instruments and defense...
-
PALO ALTO, Calif., May 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and...
-
ROCHESTER, NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical optics to scientific and...
-
May 22, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises Proceeds Cover Year 1 eRapa Phase 3 Obligations, Unlocking...